Doi, T., Tajimi, M., Mori, J., Asou, H., Inoue, K., Benhadji, K. A., & Naito, Y. (2020). A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors. Invest New Drugs.
Chicago Style CitationDoi, Toshihiko, Masaomi Tajimi, Joji Mori, Hiroya Asou, Koichi Inoue, Karim A. Benhadji, i Yoichi Naito. "A Phase 1 Study of Crenigacestat (LY3039478), the Notch Inhibitor, in Japanese Patients With Advanced Solid Tumors." Invest New Drugs 2020.
Cita MLADoi, Toshihiko, et al. "A Phase 1 Study of Crenigacestat (LY3039478), the Notch Inhibitor, in Japanese Patients With Advanced Solid Tumors." Invest New Drugs 2020.
Atenció: Aquestes cites poden no estar 100% correctes.